November 13, 2018 Subject: MD&A for the financial statements of the 3rd quarter of fiscal year 2018 ended as of September 30, 2018 To: The President The Stock Exchange of Thailand Aapico Hitech Public
, 2020 Subject Management’ discussion and analysis for the fiscal year ended December 31, 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited ( “ the Company” ) would like
จดหมายชี้แจงปี60e February 22, 2018 The Managing Director The Stock Exchange of Thailand Subject : Management Discussion and Analysis Ending 31 December 2017 Summary of operating result between 2017
Million Baht 2020 2019 Sales 1,756.01 1,684.73 Cost of Sales 1,475.46 1,586.07 Gross Margin 280.55 98.66 Gain (loss) on exchange rates (23.34) 21.83 Other Incomes 27.64 4.97 Total Revenues 1,783.65 1,711.52
Mr. Surin Banyongponglert From 25 July 2017 to 9 August 2017 (total 11 working days), Mr. Surin Banyongponglert traded PICO shares via his 4 trading accounts on a continued basis with an intent to
. Actual value may change depending on the exchange rate being effected as of the transaction date 8 Value of total considerations the Company pay for higher proportion of shareholding in ICUK from 51.0% to
-month period ending 30 September 2017 5. Total Considerations and Payment Conditions - Translation - Enclosure 1 Value in Thai Baht (THB) as converted from Great British Pound (GBP) is based on exchange
1 (Translation) MD. 063/2018 May 9 , 2018 Re: Management Discussion and Analysis For the Operating Results ended March 31, 2018 To: President The Stock Exchange of Thailand Management Discussion and
Discussion and Analysis of the Company’s Performance for the three-month period ended March 31, 2019 Baht Million 2018 2019 +/(-) +/(-) % Total revenues 345.79 424.07 78.28 22.64% EBIT 108.28 121.12 12.84